Marker2, while I agree with most you wrote here I'm sure you missed my point of why I post this article. The Pharma Letter is not some tiny Australian newsletter and has a very far reach:
"About The Pharma Letter The Pharma Letter provides accurate, unbiased business information on the worldwide pharmaceutical, generic and biotechnology industries.
Thousands of executives in these and allied organisations find The Pharma Letter a necessary read to keep them the first to know about current news and events, written whilst the news is fresh and has the greatest impact on commercial decisions"
I have never seen them announce anything in the Health/Biotech space that has something to do with simple Australian achievements and to do with our smaller companies. The majority of news from them comes when a major is involved, when the broader pharma/biotech fraternity would be interested, so I think our news being relayed here can only be a good thing if not for exposure itself.
I have said and will say again that I'm happy for the selling pressure coming in from these guys because it gives me the opportunity to increase my holdings while the market cap is where it is, I disclose LT Buy for a reason and I personally see it as opportunity.
HAGWEA
PYC Price at posting:
6.6¢ Sentiment: LT Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)